Technical Analysis for PULM - Pulmatrix, Inc.

Grade Last Price % Change Price Change
D 1.83 1.98% 0.04
PULM closed up 1.98 percent on Wednesday, May 15, 2024, on 75 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 1.98%
Doji - Bullish? Reversal 1.98%
Lower Bollinger Band Touch Weakness 1.98%
Oversold Stochastic Weakness 1.98%
NR7 Range Contraction 2.81%
Earnings Movers Other 2.81%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 15 hours ago
50 DMA Support about 15 hours ago
Rose Above 50 DMA about 15 hours ago
Rose Above 10 DMA about 15 hours ago
Gapped Up (Full) about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company's proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease and other treatments. Pulmatrix, Inc. is based in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Clinical Development Rare Diseases Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Cystic Fibrosis Pulmonary Disease Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation

Is PULM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.9103
52 Week Low 1.55
Average Volume 15,446
200-Day Moving Average 1.99
50-Day Moving Average 1.87
20-Day Moving Average 1.92
10-Day Moving Average 1.87
Average True Range 0.13
RSI (14) 44.75
ADX 14.55
+DI 23.46
-DI 15.84
Chandelier Exit (Long, 3 ATRs) 1.80
Chandelier Exit (Short, 3 ATRs) 2.12
Upper Bollinger Bands 2.11
Lower Bollinger Band 1.74
Percent B (%b) 0.24
BandWidth 18.91
MACD Line -0.03
MACD Signal Line -0.01
MACD Histogram -0.023
Fundamentals Value
Market Cap 6.68 Million
Num Shares 3.65 Million
EPS -4.44
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 0.94
Price-to-Book 0.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.10
Resistance 3 (R3) 2.12 2.05 2.05
Resistance 2 (R2) 2.05 1.98 2.04 2.04
Resistance 1 (R1) 1.94 1.94 1.91 1.92 2.02
Pivot Point 1.87 1.87 1.85 1.86 1.87
Support 1 (S1) 1.76 1.80 1.73 1.74 1.64
Support 2 (S2) 1.69 1.76 1.68 1.62
Support 3 (S3) 1.58 1.69 1.61
Support 4 (S4) 1.56